Pharmacotherapy with statins in highand very high-risk elderly patients

This review focuses on the prevention of cardiovascular diseases and their complications in elderly patients. It discusses disease diagnosis, its verification, and risk stratification of patients. Highand very highrisk patients should receive aggressive lipid-regulating pharmacotherapy with statins...

Full description

Bibliographic Details
Main Authors: V. V. Simerzin, O. V. Fatenkov, D. R. Nizametdinova, S. V. Bulgakova, M. A. Galkina, Ya. A. Panisheva, A. V. Gagloev, E. K. Serpionova, I. Kh. Sytdykov, Ya. O. Popova
Format: Article
Language:Russian
Published: Private institution educational organization of higher education "Medical University "ReaViz" 2020-11-01
Series:Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:
Online Access:https://vestnik.reaviz.ru/jour/article/view/6
_version_ 1797695069589864448
author V. V. Simerzin
O. V. Fatenkov
D. R. Nizametdinova
S. V. Bulgakova
M. A. Galkina
Ya. A. Panisheva
A. V. Gagloev
E. K. Serpionova
I. Kh. Sytdykov
Ya. O. Popova
author_facet V. V. Simerzin
O. V. Fatenkov
D. R. Nizametdinova
S. V. Bulgakova
M. A. Galkina
Ya. A. Panisheva
A. V. Gagloev
E. K. Serpionova
I. Kh. Sytdykov
Ya. O. Popova
author_sort V. V. Simerzin
collection DOAJ
description This review focuses on the prevention of cardiovascular diseases and their complications in elderly patients. It discusses disease diagnosis, its verification, and risk stratification of patients. Highand very highrisk patients should receive aggressive lipid-regulating pharmacotherapy with statins in order to control the level of low-density lipoprotein-cholesterol. Such therapy has some specific features in elderly patients.
first_indexed 2024-03-12T03:05:56Z
format Article
id doaj.art-4755a51f45844028a574599fa62a90e9
institution Directory Open Access Journal
issn 2226-762X
2782-1579
language Russian
last_indexed 2024-03-12T03:05:56Z
publishDate 2020-11-01
publisher Private institution educational organization of higher education "Medical University "ReaViz"
record_format Article
series Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
spelling doaj.art-4755a51f45844028a574599fa62a90e92023-09-03T14:32:47ZrusPrivate institution educational organization of higher education "Medical University "ReaViz"Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье2226-762X2782-15792020-11-010145534Pharmacotherapy with statins in highand very high-risk elderly patientsV. V. Simerzin0O. V. Fatenkov1D. R. Nizametdinova2S. V. Bulgakova3M. A. Galkina4Ya. A. Panisheva5A. V. Gagloev6E. K. Serpionova7I. Kh. Sytdykov8Ya. O. Popova9ФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииЧастное учреждение образовательная организация высшего образования «Медицинский университет «Реавиз»ФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииКлиники ФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииКлиники ФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииКлиники ФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииThis review focuses on the prevention of cardiovascular diseases and their complications in elderly patients. It discusses disease diagnosis, its verification, and risk stratification of patients. Highand very highrisk patients should receive aggressive lipid-regulating pharmacotherapy with statins in order to control the level of low-density lipoprotein-cholesterol. Such therapy has some specific features in elderly patients.https://vestnik.reaviz.ru/jour/article/view/6профилактикапожилой возрастфармакотерапия статинамириск-стратификацияскрининг
spellingShingle V. V. Simerzin
O. V. Fatenkov
D. R. Nizametdinova
S. V. Bulgakova
M. A. Galkina
Ya. A. Panisheva
A. V. Gagloev
E. K. Serpionova
I. Kh. Sytdykov
Ya. O. Popova
Pharmacotherapy with statins in highand very high-risk elderly patients
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
профилактика
пожилой возраст
фармакотерапия статинами
риск-стратификация
скрининг
title Pharmacotherapy with statins in highand very high-risk elderly patients
title_full Pharmacotherapy with statins in highand very high-risk elderly patients
title_fullStr Pharmacotherapy with statins in highand very high-risk elderly patients
title_full_unstemmed Pharmacotherapy with statins in highand very high-risk elderly patients
title_short Pharmacotherapy with statins in highand very high-risk elderly patients
title_sort pharmacotherapy with statins in highand very high risk elderly patients
topic профилактика
пожилой возраст
фармакотерапия статинами
риск-стратификация
скрининг
url https://vestnik.reaviz.ru/jour/article/view/6
work_keys_str_mv AT vvsimerzin pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT ovfatenkov pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT drnizametdinova pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT svbulgakova pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT magalkina pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT yaapanisheva pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT avgagloev pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT ekserpionova pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT ikhsytdykov pharmacotherapywithstatinsinhighandveryhighriskelderlypatients
AT yaopopova pharmacotherapywithstatinsinhighandveryhighriskelderlypatients